Introduction
New drugs are registered for use in the general population after an elaborate process of development, toxicological studies, and randomized controlled trials. New knowledge about wanted and unwanted effects is also gained after the introduction of a drug for use in the general population.
Pharmacoepidemiology is the study of characteristics of groups of recipients of specific drugs and of the effects of drugs in large populations. One of the issues in pharmacoepidemiology is the quality of the data on drug exposure. Our work centred on methods for ascertaining drug use and on methods to interpret drug histories of large groups of patients. The exposition data of the studies were Dutch pharmacy data. It was possible to gather large numbers of complete or nearly-complete computerized outpatient prescription drug histories from the general population.
Prescription sequence analysis
Prescription sequence analysis is a method to be applied for drugs with a possible side-effect that could lead to a condition for which specific drug therapy is available. If such side-effects indeed occurred with any appreciable incidence, they would be revealed by a characteristic sequence of prescriptions in patients' drug histories. The technique is to be used to assess the risk of certain drugs in situations where an urgent need arises to obtain information about the plausibility of reports of an adverse drug reaction.
An analysis was made of computerized drug histories of users of the antimigraine/antivertigo drug flunarizine, after the publication of case reports suggesting that the drug might cause mental depression and parkinsonism. We selected the drug histories from patients who had received both flunarizine and an antidepressant drug a_t some time in the available history. The initiation (i.e. 'start') of antidepressant therapy was considered to be a marker of the occurrence of mental depression. The occurrence of these starts were compared in the periods before, during and long after the dispensing of flunarizine, tn the largest of our two studies the incidence of antidepressant starts was slightly higher during flunarizine use than before or long after (risk ratio 1.34). Consequently, the possibility that flunarizine induces drug-treated mental depression cannot be excluded, although the association found could be explained by alternative mechanisms.
An additional finding was that a remarkably large proportion of the recipients of flunarizine had received an antidepressant drug at some time during the available drug history. Therefore, it appears that flunarizine is prescribed to a group of patients for whom antidepressant drugs are frequently prescribed, presumably indicative of an unusual preva- lence of depression or depression-like symptoms in these patients. This kind of knowlegde on the background of drug-treated persons should be relevant for other types of studies which try to distinguish a drug effect from a condition already present in the persons studied.
For another application of prescription sequence analysis a selection was made of patients' drug histories that include inhaled steroids and topical oral anticandida medication. The use of inhaled steroids (A) can induce oral candidiasis, and we considered the dispensing of topical oral anticandida medication (B) to be a marker of oral candidiasis. Thus, A can cause oral candidiasis, while B is a therapy for this condition. In this analysis a positive association, though not a strong one, was found between exposure to inhaled steroids and start of anticandida drugs (risk ratio 1.43).
Channeling
Channeling occurs when drugs with similar therapeutic indications are prescribed to groups of patients with a different health status or prognostic characteristics. Time of introduction or specific marketing claims may result in channeling of a new drug to a group of patients different from the users of pharmacologically closely related drugs. We studied whether asthma drugs in one pharmacologic class, the ~2-agonist class, are channeled to patients with a different severity of asthma, as expressed by concomitant medication. The drug histories of recipients of three inhalaUonal /32-agonists (salbutamol, fenoterol and terbutatine) were compared for markers of severe or difficult-to-treat asthma. We considered the use of systemic corticosteroids by asthmatics to be such a marker of severe or difficult-to-treat asthma. In a data base covering the medication of 121,000 persons the drug histories of recipients of one of the three inhalational ~2-agonists were retrieved and analysed. We found 2-2.5 times more co-medication with systemic steroid drugs in the group of recipients of fenoterol than in the recipients of salbutamol. Terbutaline recipients were intermediate. Also, the proportion of patients with one or more other asthma drugs was highest among fenoterol recipients and lowest among salbutamol recipients; terbutaline was again intermediate in this respect. Therefore, it appears that Dutch physicians prescribe terbutaline and fenoterol to patients with more severe forms of asthma than salbutamol.
Use of drugs after hospital admission
A problem of unintended cessation of medication in patients who were admitted to hospital is reported in the literature. In view of this, we studied the continuity of medication of a group of patients admitted to a Dutch hospital. Out-patient drug histories from the only pharmacy in one of the towns in the hospital's catchment area were matched to records of drugs dispensed to patients during their stay in the near-by hospital. The hospital and pharmacy records of 205 patients were reviewed with the help of an expert panel. The discrepancies were classified by this panel as to their potential seriousness. When we found what appeared to be serious discrepancies, we consulted the patient's medical record to ascertain, from the subsequent course of events, whether the stopping of medication had been inadvertent or intentional. The panel judged 68 'stops,' involving 41 patients, as potentially hazardous if done accidentally. Examination of the medical records led to the conclusion that 15 inadvertent drug discontinuations of a more serious nature occurred, involving 12 patients.
The results are not necessarily representative of the overall Dutch situation, but they indicate that there are errors that can be reduced. Improvement is suggested through transmission of computerized data from the community pharmacy to the hospital whenever a patient is admitted.
Validity of information on the use of drugs
Information from a patient questionnaire on chronic use of drugs was validated with the help of pharmacy data. The questionnaire was used in a large-scale prospective cohort study on diet, othe~ lifestyle factors (such as long-term drug use) and the incidence of cancer. The validity of the information on drug use was investigated by comparing the questionnaire data with pharmacy records on dispensed drugs. The validation study was conducted in a municipality served by one pharmacy for the persons who had returned the questionnaire.
All drugs mentioned in the questionnaire to be used at the moment of the baseline measurement were traceable in the pharmacy record. Since there were no errors of commission -i.e. drugs mentioned but not dispensed in the pharmacy -the analyses were focused on errors of omission -drugs dispensed but not mentioned in the questionnaire. Of the 207 cohort members 69 chronically received drugs at the time of the baseline measurement. On average, these participants received 1.9 drugs for at least 6 months. Overall, 68,8% of current long-term use was correctly reported. Drugs chronically dispensed but whose use ceased before the baseline measurement were reported less adequately.
In conclusion, the open-ended question on drug use had a high specificity but a rather low sensitivity, i.e. the absence of false-positive answers is accompanied by defaults in the reporting of drugs that were dispensed to cohort members. Relevant for other studies in pharmacoepidemiology is the high reliability of the Dutch pharmacy data when a history of the drugs received by individuals is required.
